enow.com Web Search

  1. Ads

    related to: linzess reviews & patient comments

Search results

  1. Results from the WOW.Com Content Network
  2. Linaclotide - Wikipedia

    en.wikipedia.org/wiki/Linaclotide

    Linaclotide, (sold under the brand name Linzess in the US and Mexico, and as Constella elsewhere) [6] is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.

  3. Ironwood Pharmaceuticals Provides Fourth Quarter 2012 Investor Update Initiated Promotional Efforts for LINZESS™ (linaclotide) with Forest in December 2012; LINZESS Available to Patients in ...

  4. Ironwood Rides on Linzess' Progress, Stalls Lenisurad Drugs - AOL

    www.aol.com/news/ironwood-rides-linzess-apos...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Ironwood Pharmaceuticals Provides Second Quarter 2013 ...

    www.aol.com/news/2013-07-23-ironwood...

    Ironwood Pharmaceuticals Provides Second Quarter 2013 Investor Update Second quarter LINZESS ® (linaclotide) net product sales of $28.8 million, as reported by Forest Laboratories, Inc. CAMBRIDGE ...

  6. Eluxadoline - Wikipedia

    en.wikipedia.org/wiki/Eluxadoline

    An FDA review found that in such patients, spasm of the sphincter of Oddi may lead to severe pancreatitis. [10] The FDA reported that in some cases symptoms have occurred with just one or two doses at the recommended dosage for patients without a gallbladder (75 mg). [ 10 ]

  7. Plecanatide - Wikipedia

    en.wikipedia.org/wiki/Plecanatide

    Plecanatide, sold under the brand name Trulance, is a medication for the treatment of chronic idiopathic constipation (CIC) [4] and irritable bowel syndrome with constipation. [5]

  8. Converting the Dissatisfied - AOL

    www.aol.com/news/2012-08-31-converting-the...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Morgan Stanley Turns Bearish On Ironwood Pharma, Lowers ... - AOL

    www.aol.com/news/morgan-stanley-turns-bearish...

    Commercial stage biopharma company Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD )'s Linzess, which it markets along with Allergan plc (NYSE: AGN ) in the U.S., is a major revenue earner for the ...

  1. Ads

    related to: linzess reviews & patient comments